Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Hope against Hype - Cancer Stem cells & Oncology Research
- Cancer Stem Cells 2020

Welcome message


We extend our hearty welcome to all the participants to CANCER STEM CELL 2020 scheduled on September 21-22,2020 at AMSTERDAM, NETHERLANDS with a theme “Hope against Hype – Cancer stem cells & Oncology Research ". We organize Global Events with Conferences, Symposiums and Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

               We gladly welcome all the attendees around the world for the hearing of the foremost recent innovations and inventions in the field of cancer. This Conference will provide a place for the exchange of ideas and views by leading scientists, researchers and also from the academicians around the globe. There will be many outstanding keynote speakers and well known leading scientists and experts from various places of the globe to share their ideas and talk about various aspects related to the field of Cancer stem cells. Our aim is to gather peer researchers, young scientists, academicians & industrialists to meet, discuss and share the ideas related to it and the knowledge that’s still more to be revealed. We heartily encourage you to attend and contribute to one of the major events of 2020 in the field of Cancer stem cells. The conference will reveal the present and future aspects in the field of Cancer stem cell which are the need for instant and better treatment.


 Who and Why??


Cancer Stem Cells – 2020 Conference brings together the specialists from all the aspects to discuss about the future of Oncology and Cancer in today’s world to thrive and survive with a better health. Directors specialists, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies, Healthcare Institutions, Market Research and Consulting Firms, Pharmaceutical Companies and all other interested participants willing to enhance and update the knowledge may attend the conference.


Cancer Stem Cells & Oncology:


The branch of health care that determines the safety & efficacy of medications, devices, and diagnostics and also treatments intended for human use is termed  Clinical Research .These are used for the treatment , prevention, diagnosis and relieving symptoms of the diseases. Clinical research may differ from clinical practice. Clinical Practice uses established process , whereas in case of clinical research evidence is collected for establishing the new treatment using “biological marker” .i.e. Biomarker refers to the category of medical signs or say objective indications of the medical state which is observed from outside the patient – and is measured accurately.

Scientific Sessions


Track 1: Cancer Stem Cell


Cancer Stem Cell(CSC) hypothesizes the presence of a little populace of diseased cells with characteristic properties like protection from traditional radio-chemotherapy regiments and increased metastatic potential. Clinically, the forceful idea of CSCs has been appeared to connect with tumour repeat, metastatic spread, and generally very low patient result over various malignant growth subtypes. Separation of CSC’s has been achieved through the use of cell surface markers by the useful contrasts among CSCs and remaining tumour cells have been portrayed through expansion, separation, and constraining weakening measures.


Track 2: Oncology Research



Oncology is a part of the medication that bargains with the anticipation, conclusion, and treatment of Cancer disease. Survival has been enhanced because of three primary segments including enhanced counteractive action endeavours to diminish presentation to chance elements (e.g., tobacco smoking and liquor utilization) enhanced screening of a few tumours (taking into consideration prior finding), and upgrades in treatment.


Malignant growths are regularly overseen through discourse on multi-disciplinary disease gatherings where radiation oncologists, pathologists, radiologists, and organ particular oncologists meet to locate the most ideal administration for an individual patient considering the physical, social, mental, and money related status of the patient. It is vital for oncologists to keep refreshed as for the most recent headways in oncology, as changes in administration of malignancy are very normal.


Track 3: Oncology Research Categories


Cancer Oncology examines are being led remembering different classes or criteria like area, influenced organ, sort of Cancerdisease, kind of consideration or drug, condition or encompassing. Research may be done in any of the fields like Gynaecological oncology, Paediatric Oncology, Geriatric Oncology, through the research done the treatment pattern can be determined further.


Track 4: Stem Cells


Stem Cells are Biological cells that can separate into different sorts of cells and can divide to deliver same kind of cells in huge numbers. They are found in multicellular life forms. In mammals, there are two wide kinds of stem cells: embryonic stem cells, which are isolated from the internal cell mass of blastocysts, and adult stem cells, which are found in different tissues.

Track 5: Bio-markers of Cancer Stem Cells


Liver cancer is the fifth most analysed and the second most ceaseless reason for cancer death in men around the world. Amongst liver cancers, hepatocellular carcinoma (HCC) represents the major histological subtype and it is one of the most common malignant human tumours. Research into the molecular biology of hepato-carcinogenesis has identified several biomarkers, which could provide additional information in order to better understand the biology of HCC. A large number of biomarkers have been shown to have probable predictive significance and a wide variety of molecular markers have been proven to be excellent diagnostic tools for HCC however it is hard to represent HCC with a single biomarker. Therefore, marks of a mix of biomarkers might be more important for the finding, arranging and visualization of HCC. Specifically, a correlation of HCC-CSCs phenotype to specific hepatic cancer subtypes and to specific clinical and pathological features has not yet been reported in human liver tumours.

Track 6: Immunology


Immunology is a part of science that covers the study of immune systems in all living beings. Immunology outlines, measures, and contextualizes the physiological working of the immune system in conditions of both wellbeing and sicknesses; breakdowns of the immune system in immunological disorders , example : autoimmune diseaseshypersensitivitiesimmune deficiency, and rejection of transplants: the physical, compound and physiological attributes of the segments of the  immune system in vitro, in situ, and in vivo. Immunology has applications in various orders of medication, especially in the fields of organ transplantation, oncology, rheumatology, virology, bacteriology, parasitology, psychiatry, and dermatology.


Track 7: Cancer Stem Cell Treatments


Cancer treatments against tumor, chemo-andradiotherapy, have various restrictions that prompt treatment disappointment and disease repeat. These cells are associated with tumor formation, support, metastasis and repeat. Consequently, with the end goal to create productive medicines that can prompt a dependable clinical reaction forestalling tumor backslide it is vital to create drugs that can particularly target and dispose of CSCs. On-going distinguishing proof of surface markers and comprehension of atomic element is related with CSC phenotype, assisted with the plan of viable medicines


Track 8: Types of Cancer


Cancer types include Carcinoma, Sarcoma, tumours got from epithelial cells. This gathering incorporates a large number of the most widely recognized malignancies and incorporate almost each one of those in the prostate, lung, pancreas and colon.


Track 9: Nanotechnology in Cancer


Cancer nanotechnology is a part of nanotechnology which deals with various techniques, equipment’s also known as Nano-materials to the analysis and treatment of cancer. It is the branch of nanotechnology that uses Nano-science and Nano vectors to cure or stop cancer cells and their growth


Track 10: Cancer Stages


Organizing can be "clinical" or "neurotic." Clinical organizing is based on the after effects of the tests done prior to the medical procedure for example:  physical examinations and imaging filters. Neurotic organizing based on what is found through the medical procedure.Clinical stage is regularly demonstrated by a lowercase "c" before the TNM grouping. The obsessive stage is demonstrated by a lowercase "p."

Track 11: Cancer Causes


There can be more than one reason for cancer cells formation and growth. Various powers can cause quality changes, for example, smoking, radiation, infections, Cancer causing synthetic compounds (cancer-causing agents), heftiness, hormones, endless aggravation and an absence of activity.


 Track 12: Cancer Treatment


The causes for cancer may differ from genetic to the lifestyle of an individual. Cancer can spread from one region of the body to another and can also lead to death, there are some ways to treat or to reduce the spread of it.


Track 13: Cancer Prevention


Cancer Prevention contains steps that are taken to bring down the danger of getting the Cancer disease. This can incorporate keeping up a solid way of life, to know disease causing substances, and taking prescriptions or immunizations that can keep cancer from formation.

  • Proper and Healthy Diet
  • Medication
  • Change in Lifestyle


Track 14: Clinical Research and Trials in Stem Cells and Cancer


Clinical preliminaries are broadly observed for real advances in Cancer treatment because of developing new medications to avert or help oversee Graft-Versus-Host Disease (GvHD). Graft-Versus-Host Disease a typical and conceivably extreme reaction of stem cell transplants in which contributor safe cells attack solid patient cells and tissues. Creating cancer immunization systems for use alongside transplant to invigorate the Graft-Versus- leukaemia (GVL) impact and limit malady backslide. Graft-versus-Leukaemia has restorative impact in which transplanted invulnerable cells attack leftover leukaemia or other tumour cells


Track 15: Bioinformatics and Systems Biology


Bioinformatics and System Biology utilize PC techniques to investigate the natural information. As opposed to the past attention on single qualities or proteins, frameworks science is a field of research which focuses on understanding whole natural frameworks, for example: protein buildings, metabolic pathways, or quality administrative systems.

  • Molecules and Cells
  • Genes, Systems, and Evolution
  • Statistics in Biology
  • Applied Genomics
  • Programming for Biologists
  • Biological Databases and Data mining
  • Bioinformatics and Evolutionary Genomics


Track 16: 3D Bio printing & Bio fabrication


Bio fabrication is alluded to the generation of fake tissues or organs to address well being challenges in medication. It frequently utilizes the rule of 3D Bio printing to shape cells, gels and strands into an organ.

  • Bioprinting using microfluidics
  • Bio inks
  • Engineered Tissue
  • 3D printing technologies
  • Innovative development in 3D-bioprinting
  • Intelligent bio materials


 Track 17: Gene Therapy


Gene Therapy is an exploratory strategy that utilizes qualities to treat or anticipate ailment. Later on, this strategy may enable specialists to treat confusion by embedding a quality into a patient's cells as opposed to utilizing medications or medical procedure. In spite of the fact that gene therapy is a promising treatment alternative for various ailments (counting acquired disarranges, a few sorts of malignancy, and certain viral contaminations), the system stays hazardous is still under examination to ensure that it will be protected and successful. Gene Therapy is as of now being tried just for maladies that have no different fixes


 Track 18: Stem Cell Biology and Advances


Most of the structural microorganisms have the astonishing potential to form into a wide range of cell types, basically unlimited to renew different cells until the individual is alive, offering any expectation of relieving Alzheimer's disease , treating kidney, liver and lung diseases . Until today, researchers principally worked with two types of undistinguishable organisms from creatures and people that are embryonic foundational microorganisms and non-embryonic "physical" or "grown-up" undeveloped cells. Late leap forward make it conceivable to change over or "reconstruct" specific grown-up cells to expect a stem cell with various improvements. The audit will quickly talk about the on-going developments here.


 Track 19: Advances in Tissue Regeneration


Tissue Engineering is a logical field and depicted as understanding the benchmarks of tissue and its improvement by handy exchange of insufficient tissue for clinical use. Tissue building deals about the investigation of mixing of cells, structuring, materials and methodologies, biochemical segments to upgrade characteristic tissues. It includes the utilization of Scaffolds to shape practical tissues and organs, which can be embedded, again into the benefactor, have with the utilization of many building and materials techniques alongside some hemispherical elements. It is recognized with in excess of one branch which applies building information and life science ideas towards the advancement of natural substitutes which can enhance or re-establish all the qualities of an organ.


Track 20: Umbilical Cord Stem Cells


Moral and logical issues encompass both embryonic and fatal Cord Stem cells and frustrate their across the board usage. Interestingly, foundation microorganisms recuperated postnatal from the umbilical line, including the umbilical string platelets, amnion/placenta, umbilical rope vein, or umbilical string lattice cells, are a promptly accessible and modest wellspring of cells that are fit for framing a wide range of cell types (i.e., they are "multi-potent"). This survey will centre around the umbilical rope determined immature microorganisms and contrast those cells and grown-up bone marrow-inferred melancholy undifferentiated organisms.

  • Corneal disease
  • Umbilical cord blood transplant.


Track 21: Stem Cell and Tissue Homeostasis


Tissue homeostasis depends upon the precise direction of substantial foundational microorganism movement. Substantial undeveloped cells need to react to tissue and therefore harm and multiply as per tissue requirements, while staying away from over-multiplication. The administrative systems engaged with these reactions are presently being separated in the intestinal epithelium of Philosophical, giving new understanding into procedures and components of undeveloped cell direction in obstruction epithelial.


Track 22: Stem Cell Aging


Maturing tissues encounter a dynamic decrease in homeostatic and regenerative limits, which has been credited to degenerative changes in tissue-particular foundation microorganisms, undifferentiated organism specialties and fundamental signals that manage undeveloped cell action. Understanding the sub-atomic pathways associated with this age-subordinate crumbling of immature microorganism capacity will be basic for growing new treatments for maladies of maturing that objective the particular reasons for age-related utilitarian decay. Here we investigate key sub-atomic pathways that are generally irritated as tissues and undifferentiated organisms age and savage.

  • Theories of aging
  • Theories of biological aging
  • Proximate theories of biological aging
  • Alzheimer‘s disease
  • Cardiovascular diseases


Track 23: Stem Cell Therapy


Essential microorganisms are the body's rough materials cells from which each other cell with particular boundaries are created. New stem cells either end up being new undifferentiated cells with a more specific limit for instance: platelets, mind cells, heart muscle cells or bone cells. No other cell in the body has the featured ability to make new cell types.

  • Acute Lymphoblastic Leukaemia
  • Acute Megakaryocytic Leukaemia
  • Acute Myelomonocytic Leukaemia
  • Lymphoma Cancer
  • Immune Cell Therapy
  • Allogeneic transplantation.
  • Advances in Bone Marrow Stem Cell


Track 24: Recent Advances in Stem Cell


All the immature microorganisms possess an amazing potential to form into various cell types, basically unbounded to renew different cells as long as the individual is alive, thus offering monstrous any desire for relieving Alzheimer's ailment, fixing harmed spinal lines, treating kidney, liver and lung sicknesses. Until today, researchers essentially worked with two sorts of undeveloped cells from creatures and people: embryonic undifferentiated cells and non-embryonic "substantial" micro-organisms. On-going achievement makes it conceivable to change over or "re-invent" specific grown-up cells to expect stem-like cells with various advancements. The survey will quickly talk about the on-going advances here.

  • Embryonic stem cells
  • Somatic cell nuclear transfer (SCNT)
  • Induced pluripotent stem cell (iPSC)
  • Stimulus-triggered acquisition of pluripotency (STAP)
  • Adult Stem Cells
  • Adult Neural Stem Cells


Track 25: Epidermal Stem Cells


The skin continually re-establishes itself for the duration of grown-up life, and the hair follicle experiences an interminable cycle of development and degeneration.  Microorganisms
(Stem cells) dwelling in the
epidermis and hair follicle guarantee the support of grown-up skin homeostasis and hair recovery, however they likewise take part in the fixation of the epidermis after wounds.

  • Stem cells with in adult skin epithelium
  • Signalling and stem cell fate specification in the skin
  • Bone Morphogenetic Protein Signalling
  • Notch Signalling


Track 26: Stem Cell Renewal


In numerous tissues, mammalian maturing is linked with a decrease in the replicative and effective limit of physical immature microorganisms and other self-recharging compartments. Therefore understanding the premise of this decay is a noteworthy objective of maturing research. . Such methodologies incorporate accomplishments to shield undifferentiated organisms from age-advancing harm, to 'revive' foundation microorganisms using pharmacologic specialists that moderate maturing impelled modifications in flagging, and to replace lost undeveloped cells through regenerative drug approaches. Some progress has been made in every one of these fields in the course of the most recent year and a half incorporating advances in the generation of contributor particular supreme undifferentiated organisms through prompted diplomat, gains in our command of how tumour silencer flagging is controlled in self-restoring compartments to direct maturing, and further show of extracellular 'milieu' factors that bother undeveloped cell work with age.


Track 27: Ethics Considerations in Stem Cell Therapy


Stem Cell Research offers incredible guarantee for understanding fundamental elements of human advancement and separation, additionally the expectation for new medications for illnesses, for example, diabetes, spinal line damage, Parkinson's ailment, and myocardial localized necrosis. In any case, human Stem Cell inquires about additionally raises sharp moral and political contentions. The reconstructing of substantial cells to deliver instigated pluripotent undifferentiated organisms keeps away from the moral issues particular to embryonic microorganism examine. In any hSC look into, be that as it may, troublesome problems emerge with respect to delicate downstream research, agree to give materials for hSC explore, early clinical preliminaries of  hSC treatments, and oversight of hSC inquire about. These moral and strategy issues should be talked about alongside logical difficulties to guarantee that undeveloped cell examine is done in a morally suitable way. This article gives a basic investigation of these issues and how they are tended to in current approaches


Track 28: Advances in Developmental Biology and Stem Cells


Developmental biology is proposed as "the stem cell of biological disciplines." Genetics, cell science, oncology, immunology, transformative components, neurobiology, and frameworks science has its heritage in formative science. Formative science keeps on moving on, while holding its very own character. While its relative controls separate into sciences with a limited arrangement of standards, precedents, and systems, formative science stays incredible, pluripotent, and generally undifferentiated. In numerous orders, particularly in transformative science and oncology the developmental point of view is being reaffirmed as a critical research program.


  • Tissue compartmentalisation
  • Oncogenic perturbation of stem cell behaviour
  • Compartmentalisation and heterogeneity beyond the epidermis

About the Venue



Amsterdam is the capital city of the Netherlands. It is also referred as the "Venice of the North" because of the large number of canals.


Amsterdam's name has been derived from Amstelredamme, which indicates the city's origin around a dam in the river Amstel. Many large institutions have established their headquarters, which includes Philips, Tom Tom, ING and etc.; many of the world's largest companies which are located in Amsterdam have their European headquarters in the city, such as leading technology companies like Uber, Netflix and Tesla.

Tourist places:

The tourist places include the city’s historic canals, the Rijksmuseum, Hermitage Amsterdam, the Van Gogh Museum, the Stedelijk Museum, the Concertgebouw, the Anne Frank House, the Amsterdam Museum, the Royal Palace of Amsterdam, Natura Artis Magistra, Hortus Botanicus Amsterdam, NEMO and many cannabis coffee shops. They draw about 5 million international visitors annually.


In the 17th and 18th century, Amsterdam was a city where immigrants made the majority. Most immigrants were Lutheran Protestant Germans, French Huguenots, or Spanish Jews. There was also an inflow of Flemish refugees following the fall of Antwerp.


It is a city of technological prowess; it is a home for approx. 578 ICT companies. The city is ranked 4th globally in app invention and developments. Various Silicon Valley companies have been set up including Salesforce, DoubleDutch and Cisco.

Amsterdam is trying to increase its tech talent pool, the city’s start-up’s received funding of €194m last year – a whopping 76% of the Netherlands’ total start-up funding, with tech companies.


By the end of the 19th century, the Industrial Revolution extended in Amsterdam. The Amsterdam-Rijn kanaal was mined to give Amsterdam a direct connection to the Rhine and the Noordzee kanaal to give connection with the North Sea. Both the projects improved communication with the rest of Europe and the world intensely. They gave the economy a big lift.


During 1995, the national government planned the creation of a 'city province', comprising of Amsterdam and neighbouring towns. This proposal was forbidden by the people in a referendum. The opposition was not against creating the city province as it was against the splitting of the city into parts. Opposers feared this would abolish the city's cohesion. After the referendum, the city province proposal was dropped. Since 1995, city parts have gradually become more autonomous, and neighbouring towns have been drawn into the city, politically and economically. The city province has attained in the form of 'Greater Amsterdam'.


21st century:

In the early ages of the twenty-first century, the Amsterdam city centre successfully fascinated large numbers of tourists by means of campaigns such as I Amsterdam. Between 2012 and 2015, 3000 hotel rooms were built; Airbnb further brought another 11.000 accommodations and the annual number of tourists rose from 10 million to 17 million. Real estate prices have increased, making the centre high-priced for the city's inhabitants, while local shops are making way for tourist-oriented ones. These developments have induced comparisons with Venice, a city already astounded by the tourist influx.

                        One thing is for sure: by 2020, when people talk about technology, scientific innovation and start-ups, Amsterdam’s accomplishments will come up just as much as Silicon Valley’s.

Market Analysis



We invite all the participants throughout the globe to join at the Conference on Cancer Stem Cells & Oncology Research which is going to be held during September 21-22,2020 at Amsterdam, Netherlands which will include, Oral talks, keynote presentations, Poster presentations, and Exhibitions. Cancer Stem Cells 2020 is a specially planned group conference. The core theme of the conference is “Hope against Hype – Cancer stem cells & Oncology Research” which covers a wide range of important sessions.



The global stem cells market extent was estimated at USD 8.65 billion in the year 2018 and is expected to expand at a CAGR of 8.8% over the predicted period. According to the Wide Cells Group, between the years 2005 and 2013, there has been a 300% rise in the number of diseases that can be cured by stem cells.

Stem Cell Therapy Market revenue will reach $15 billion by 2025. Oncology segment held over 39% revenue in 2019. The global stem cell therapy market is expected to witness a CAGR of 10.6% during the forecast period 2019-2024, and is also predicted to reach USD 214.5 million by the end of 2024.


Importance & Scope


Cancer is second leading cause of death worldwide. Treatments that work for some cancers don’t work for the others and sometimes those treatments simply stop working and only a global search for answers will help us get to grip this disease. The conference will provide with an opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of oncology.


Cancer stem cells 2020 will also explore the new ideas and concepts on global scale and the topics Cancer Science & Therapy, Cancer Cell Biology, Organ-Defined Cancers, Tumour Science, Cancer Genetics, Clinical Cancer Research, Cancer & Tumour Immunology, Cancer : Genomics & Metabolomics, Targeted Cancer Therapy, Stem Cell Therapy, Cancer Biomarkers, Cancer Nanotechnology, Cancer Treatment and Therapeutics, Cancer Clinical Trials, Cancer Case Reports, Cancer Drug Diagnostics & Therapeutics, Precision Medicine & Cancer Therapy, Cancer Management & Prevention, Economic Impact of Cancer Therapy.


Why Amsterdam?

Amsterdam is the capital city of Netherlands. It is a hub of cancer institutes and has many centres for cancer research. In the recent years, the number of students has increased for cancer research at Netherlands Cancer Institute.

Market Analysis Report:


Cancer is a disease categorized by the uncontrolled growth and spread of abnormal cells. If the growth of these cells is not controlled, it can result in death. Cancer has more mortality rate than AIDS, tuberculosis and malaria. Based upon the income when countries are grouped, cancer is the second leading cause of death in high-income countries and the third leading cause of death in low- and middle-income countries.

Cancer Diagnostic Market:

 By Technology:

A.    Platform Based:

In situ Hybridization

Flow Cytometry

Next-generation Sequencing




B. Instrument Based:








Cancer Diagnostic Market:

By Region:


Based on region, the cancer diagnostics market is classified into North America, Europe, Asia, and Rest of the World. Rest of the World includes Latin America, Pacific countries, and Middle East and Africa. North America is predicted as the largest share in the cancer diagnostics market, followed by Europe and Asia.


List of the major performers in the cancer diagnostics system market globally are:


Sanofi (France)

Novartis (Germany)

Pfizer Inc. (U.S.)

Eli Lilly & Company (U.S.)

ImClone Systems Inc. (U.S.)

GlaxoSmithKline (U.K)

AstraZeneca (U.K)

Schering-Plough (U.S.)

Boehringer Ingelheim (Germany)

Bristol-Myers Squibb

Teva Pharmaceuticals Industries (Japan)

F. Hoffmann-La Roche Ltd (Switzerland)

Merck & Co., Inc. (U.S.)

Chemo Espana SL (Spain)


Amgen Inc (U.S.)

Bayer AG (Germany)

Takeda Pharmaceutical Company Limited (Japan)



List of Associations Worldwide:


American Association for Cancer Research

Virginia Cancer Institute

American Brain Tumor Association

American Society of Paediatric Haematology/Oncology

Association of Cancer Physicians

American Childhood Cancer Organization

American Society of Clinical Oncology

Australasian Lung Cancer Trials Group

International Cancer Research Partnership (ICRP)

American Association for Cancer Research (AACR)

American Society of Clinical Oncology (ASCO)

International Agency for Research on Cancer (IARC)

Cancer Society of New Zealand

Irish Cancer Society

Australian Cervical Cancer Foundation

Medical Centre Cologne

Cancer Research UK

Australian Prostate Cancer Research

Peter McCollum Cancer Centre

The European Cancer Organization (ECCO)

German Cancer Research Centre



List of Medical Universities worldwide:


Harvard University

University of Minnesota

Mayo Medical School

Pittsburgh School of Medicine

Yale University

University of Cambridge

University of Oxford Stanford University

Yale University

Emory University

John Hopkins University

Kings College London

Feinberg School of Medicine

University of Wisconsin

UNC School of Medicine

Karolinska University


 List of medical universities in Netherlands:

University Rotterdam

Erasmus University of Amsterdam

Utrecht University

VU University Amsterdam

Maastricht University

University of Groningen

Wageningen University and Research Center

Radboud University Nijmegen


Cancer related companies:

Roche | Sanofi | Johnson & Johnson | Merck & Co. (MSD) | Novartis | AbbVie | Gilead Sciences | GlaxoSmithKline (GSK) | Amgen | Pfizer | F. Hoffmann-La Roche Ltd | Celgene Corp | Novartis AG | Bristol-Myers Squibb Co | Samsung Medical Centre


Previous Organizing Committee Members
OCM Member
Jinsong Liu
Professor, M. D. Anderson Cancer Center
The University of Texas
Houston, USA
OCM Member
Thierry Virolle
Institut de Biologie Valrose- Ibv
Nice, France
OCM Member
Xianming Mo
West China Hospital of Sichuan University
Gungzhou, China
OCM Member
Ilio Vitale
The University of Rome Tor Vergata
Rome, Italy
OCM Member
Jiangwen Zhang
Associate Professor, School of Biological Sciences
The University of Hong Kong, Hong Kong
Tai Po, Hong Kong
OCM Member
Joo-Hyeon Lee
Department of Zoology, University of cambridge
Exeter, United Kingdom
OCM Member
Claire Acquaviva
Marseille Cancer Research Centre
Marseille, France
OCM Member
Emmanuelle Charafe-Jauffret
Institut Paoli-Calmettes
Marseille, France
OCM Member
Dean G Tang
Roswell Park Cancer Institute
Newyork, USA
OCM Member
Jingfang Ju
Stony Brook University
New York, USA
OCM Member
Yong Li,
University of New South Wales
Kensington, Australia
OCM Member
Philippe Juin
Center for Research in Cancerology and Immunology Nantes-Angers (CRCINA)
Nantes, France

Welcome to Cancer Stem Cells 2020 Conference which will be held at Amsterdam, Netherlands . The city has large number of canals and many tourist attractions.

Join The Discussion

Allied Academies Global Conference Directory

Mail us at

General Enquiry
Program Manager
Sponsorship & Collaboration
More details about

Terms and Conditions



The organizers holds no responsibilities or liabilities of the personal articles of attendees at the venue against any kind of theft, lost, damage, due to any reason whatsoever. Delegates are entirely responsible for the safety of their own belongings.



No insurance, of any kind, is included along with the registration in any of the events of the organization.




Please note that transportation and parking is the responsibility of the registrant, Allied Academies will not be liable for any actions howsoever related to transportation and parking.




Press permission must be obtained from Allied Academies Conference Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party non-profit organization and this conference is not associated with any commercial meeting company.


Requesting an Invitation Letter:


For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference after payment of complete registration fee. Once registration is complete, please contact to request for a personalized letter of invitation, if not received until one month before the scheduled date of event.

All the bank charges applicable during refund will be deducted from the account of participant.


Cancellation Policy:


All cancellations or modifications of registration must be made in writing to If, due to any reason, Allied academies postpone an event on the scheduled date, the participant is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.


Postponement of event:

If, due to any reason, Allied academies postpone an event and the participant is unable or unwilling to attend the conference on rescheduled dates, he/she is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.


Transfer of Registration:

All registrations, after payment of complete registration fee, are transferable to other persons from the same organization, if in case the person is unable to attend the event. Request for transfer of registration must be made by the registered person in writing to Details must include the full name of replaced new registrant, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

This cancellation policy was last updated on April 04, 2015.


Visa Information:

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues are not covered under the cancellation policy of Allied academies, including the inability to obtain a visa.


Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund policies apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overhead charges, following Refund Policy Orders are available:

Before 60 days of the conference: Eligible for Full Refund after deduction of $100 towards service Fee.

Within 60-30 days of Conference: Eligible for 50% of payment Refund

Within 30 days of Conference: Not eligible for Refund

E-Poster Payments will not be refunded.


Accommodation Cancellation Policy:

Accommodation Service Providers (Hotels) have their own cancellation policies which are applicable when cancellations are made less than 30 days prior to arrival. If in case the registrant wishes to cancel or amend the accommodation, he/ she is expected to inform the organizing authorities on a prior basis. Allied academies will advise the registrant to ensure complete awareness about the cancellation policy of your accommodation provider, prior to cancellation or modification of their booking.


Authorization Policy

Copyright © 2020-2021 Allied Academies, All Rights Reserved.